Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Actinium Pharmaceuticals Inc (NY: ATNM )

4.970 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jul 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 4.970
Bid (Size) 4.550 (40)
Ask (Size) 5.090 (1)
Prev. Close 4.970
Today's Range 4.970 - 4.970
52wk Range 4.410 - 10.30
Shares Outstanding 21,331,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Top Cheap Stocks: Trading Opportunities For Next Week
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some cheap stock opportunities by analyzing... 
Via Talk Markets
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today?
Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket. 
Via InvestorPlace

Performance

YTD
-22.34%
-22.34%
1 Month
-4.42%
-4.42%
3 Month
-5.15%
-5.15%
6 Month
-14.90%
-14.90%
1 Year
-33.38%
-33.38%

More News

Read More
Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Via Benzinga
Why Actinium Pharmaceuticals Stock Is Surging
Via Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Via Benzinga
Exposures Product Safety
Actinium Pharmaceuticals Rally Takes Stock 62% Higher As Its Iomab-B Data Continues To Impress (NYSE AMERICAN: ATNM)
Via AB Newswire
Exposures Product Safety
Actinium Pharmaceuticals Rally Intact As Its Iomab-B Data Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
Actinium Pharmaceuticals Stock Jumps 17% Ahead Of SIERRA Trial Update; Iomab-B Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
48 Biggest Movers From Friday
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why Actinium Pharmaceuticals' Stock Is Trading Higher Today
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Actinium's Targeted Radiotherapy Achieves 100% Bone Marrow Transplant Engraftment
Via Benzinga
Actinium Pharmaceuticals Details SIERRA at Benzinga Global Small Cap Business Conference
Via Benzinga
Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells
Via Benzinga
Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.